
Structure Therapeutics Inc.
Structure Therapeutics Inc. (GPCR)
WebsitePrice
Market cap
Next catalystExpected Q4 2026Aleniglipron (GSBR-1290) · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP2P3FilingApproved
Other pipelines
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved